Post-authorization surveillance study comparing the efficacy and safety of Medabon (mifepristone/misoprostol) to historical data for early pregnancy termination (Medabon PASS)

18/02/2014
02/07/2024
EU PAS number:
EUPAS5783
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Post-authorisation surveillance study to assess the efficacy and safety of Medabon (Mifepristone/Misoprostol) for early pregnancy termination
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

Unknown